45afb038bb2fcb720687452d025c1697 *DESCRIPTION
61d61aecf7834e3abf1b37d843bbe5c6 *INDEX
8ef682fd7c44fdacd5a7964ae8ccd22f *Meta/Rd.rds
854c930838846579e84a22a721624a4d *Meta/features.rds
211a58cf91d332033581449d3d4e35d1 *Meta/hsearch.rds
f7bad2c806108125961d7716042d3ab4 *Meta/links.rds
0c8883d7776ff025ecf21e2588b18800 *Meta/nsInfo.rds
10a8eb9374007553b0492e8956eb680b *Meta/package.rds
dac82fd309ae7f2b6597d05c01211248 *Meta/vignette.rds
06c7b940ab16bed0b32db72c57641c16 *NAMESPACE
138e40e4ef32911c915de79c972b88d4 *NEWS
d6c68f1fe41ced6e98a766a3757313da *R/TailRank
6d2e310aa7dd19ebd232bd95d810d684 *R/TailRank.rdb
32d49bbbd0632c90a35cde4c675a654c *R/TailRank.rdx
31f1d05f382647d5e4f0a77d3f1483fb *doc/betabinomial.R
98c346ecc7803a3f515bd4b337d61761 *doc/betabinomial.Rnw
7de536064e6060a4564555dc6a922df4 *doc/betabinomial.pdf
c0bb0492ec38e53e2f1933adbc0e8469 *doc/index.html
bf069052094a6f6aac5cb46df351772f *doc/tailrank.R
44c13b32186f16020e03ac81b860ed80 *doc/tailrank.Rnw
b71ec1719acdc83276ba26046b93839e *doc/tailrank.pdf
d2fc3302931447df4a96ea4e19a66421 *help/AnIndex
c3a35766e74192b3747848e9a7e06a86 *help/TailRank.rdb
22fa350eca83bdb3b166e65b88a5532a *help/TailRank.rdx
9ba6721a0fe08f6d059706dd4c9644e2 *help/aliases.rds
28a40aa0d3b10c9a0bc132e6bfea3149 *help/paths.rds
f9a63114f28199cb1f4fbc18a29d11d6 *html/00Index.html
8b9362669af13540a86a3ac6cf22f99d *html/R.css
3d20ef39e875bc27d361b7978cc1923d *sample/TR-harvard.R
d1d4a7e62343809654f3a41140380f29 *sample/TR-prostate.R
5ca9df4e71e208ad6cf9467afd6f9ca3 *sample/TR-tables.R
57203e524c5089eddb1b4ad94e5ed8c2 *sample/figs4paper.R
31735b4dbc2618b34d9635058fd69257 *sample/testing.R
